top of page
THE BIG IDEA,
TO REVOLUTINIZE
PROTEOMICS
Measuring tens to hundreds of analytes simultaneously in 5 minutes will revolutionize biomarker studies, clinical trials, and healthcare.
eGlint Technology,
Biomarker Binding Changes Biosensor Stability
General and
Quantitative
Quantifies virtually any biomarker from a blood sample
Highly
Multiplexed
Performs hundreds of assays at once
Simple and
Rapid
Delivers results within minutes without sample purification
Affordable and
Scalable
Lowers cost per sample and dramatically lowers cost per biomarker
PROTEONEX
TECHNOLOGY
eGlint’s core ProteoNex technology is versatile, allowing it to measure combinations of virtually any biomarkers
First Product: Cytokine Storm Monitoring
Potential $6.2-$9.5B Market
Number of Americans
1.7M
affected
[1]
Causes
350,000
deaths per year in the US
[1]
Treatment costs
$38B
in the US
[2]
Multiple Commercial Opportunities
INVESTORS
LEADERSHIP TEAM
$3.7B in combined exits and multiple Dx products launched
Executive Team
bottom of page